🇺🇸 FDA
Patent

US 6429232

Method of treating atherosclerosis or restenosis using microtubule stabilizing agent

expired A61KA61K31/335A61K31/337

Quick answer

US patent 6429232 (Method of treating atherosclerosis or restenosis using microtubule stabilizing agent) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 06 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/335, A61K31/337, A61K9/0024, A61P